<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	〈泰合新藥BEQIA闖美添變數！兩大藥廠提專利訴訟 FDA審查進度受矚〉的留言	</title>
	<atom:link href="https://www.li-cai.com.tw/%e6%b3%b0%e5%90%88%e6%96%b0%e8%97%a5beqia%e9%97%96%e7%be%8e%e6%b7%bb%e8%ae%8a%e6%95%b8%ef%bc%81%e5%85%a9%e5%a4%a7%e8%97%a5%e5%bb%a0%e6%8f%90%e5%b0%88%e5%88%a9%e8%a8%b4%e8%a8%9f-fda%e5%af%a9%e6%9f%a5/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.li-cai.com.tw/%e6%b3%b0%e5%90%88%e6%96%b0%e8%97%a5beqia%e9%97%96%e7%be%8e%e6%b7%bb%e8%ae%8a%e6%95%b8%ef%bc%81%e5%85%a9%e5%a4%a7%e8%97%a5%e5%bb%a0%e6%8f%90%e5%b0%88%e5%88%a9%e8%a8%b4%e8%a8%9f-fda%e5%af%a9%e6%9f%a5/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=%25e6%25b3%25b0%25e5%2590%2588%25e6%2596%25b0%25e8%2597%25a5beqia%25e9%2597%2596%25e7%25be%258e%25e6%25b7%25bb%25e8%25ae%258a%25e6%2595%25b8%25ef%25bc%2581%25e5%2585%25a9%25e5%25a4%25a7%25e8%2597%25a5%25e5%25bb%25a0%25e6%258f%2590%25e5%25b0%2588%25e5%2588%25a9%25e8%25a8%25b4%25e8%25a8%259f-fda%25e5%25af%25a9%25e6%259f%25a5</link>
	<description>聯誠國際智慧財產權事務所-台灣前十大規模之智慧財產權事務所，並榮獲各大IP評比服務滿意度優良及推薦的事務所之一。</description>
	<lastBuildDate>Wed, 04 Nov 2026 02:13:14 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
</channel>
</rss>
